Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CD34+ Stem Cells”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01895244
What this trial is testing

Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis

Who this might be right for
SclerodermaCardiac InvolvementAutologous Stem Cell Transplantation
University Hospital Tuebingen 44
Testing effectiveness (Phase 2)Study completedNCT02999984
What this trial is testing

Efficacy and Safety of the Cryopreserved Formulation of OTL-101 in Subjects With ADA-SCID

Who this might be right for
Severe Combined Immunodeficiency Due to ADA Deficiency
University of California, Los Angeles 10
Early research (Phase 1)Study completedNCT00788827
What this trial is testing

Autologous Adult Stem Cells to Patients With Type 1 Diabetes and a Successful Renal Transplant

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Imperial College London 7
Early research (Phase 1)Looking for participantsNCT06506461
What this trial is testing

Gene Editing For Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
St. Jude Children's Research Hospital 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT02797470
What this trial is testing

Gene Therapy in Treating Patients With Human Immunodeficiency Virus-Related Lymphoma Receiving Stem Cell Transplant

Who this might be right for
HIV InfectionMature T-Cell and NK-Cell Non-Hodgkin LymphomaPlasmablastic Lymphoma+8 more
AIDS Malignancy Consortium 11
Testing effectiveness (Phase 2)WithdrawnNCT00346177
What this trial is testing

Stem Cell Study for Patients With Heart Failure

Who this might be right for
Myocardial IschemiaCongestive Heart FailureCardiovascular Disease
Losordo, Douglas, M.D. 30
Testing effectiveness (Phase 2)Ended earlyNCT01121120
What this trial is testing

Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients

Who this might be right for
Lymphoma, Non-HodgkinHodgkin DiseaseMultiple Myeloma
Tarix Pharmaceuticals 75
Not applicableNo Longer AvailableNCT02026934
What this trial is testing

CliniMACS® CD34+ Reagent System for Expanded Access Use

Who this might be right for
Graft-Versus-Host Disease(GVHD)Anemia Due to Disturbance of Proliferation and/or Differentiation of Hematopoietic Stem CellsGraft Failure+1 more
Joseph Antin
Not applicableLooking for participantsNCT06896344
What this trial is testing

Role of Mesenchymal Stromal Cell Derived Extracellular Vesicles of Primary Myelofibrosis Patients on CD34+ Cells

Who this might be right for
Primary Myelofibrosis
Fondazione IRCCS Policlinico San Matteo di Pavia 10
Testing effectiveness (Phase 2)Study completedNCT00003877
What this trial is testing

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Roswell Park Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT00368355
What this trial is testing

T Cell Depletion for Recipients of HLA Haploidentical Related Donor Stem Cell Grafts

Who this might be right for
Acute Lymphoblastic LeukemiaNon Hodgkins LymphomaMyelodysplastic Syndrome+6 more
Baylor College of Medicine 46
Not applicableLooking for participantsNCT05776173
What this trial is testing

Safety and Efficacy of Gene Modified Autologous Hematopoietic Stem Cells to Treat Transfusion-dependent β-thalassemia

Who this might be right for
β-thalassemia Major
Shanghai BDgene Co., Ltd. 10
Testing effectiveness (Phase 2)Study completedNCT02151526
What this trial is testing

A Study Evaluating the Safety and Efficacy of LentiGlobin BB305 Drug Product in β-Thalassemia Major (Also Referred to as Transfusion-dependent β-Thalassemia [TDT]) and Sickle Cell Disease

Who this might be right for
Beta-Thalassemia MajorSickle Cell Disease
Genetix Biotherapeutics Inc. 7
Testing effectiveness (Phase 2)Study completedNCT00004906
What this trial is testing

Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Hackensack Meridian Health
Early research (Phase 1)Looking for participantsNCT03943238
What this trial is testing

TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation

Who this might be right for
Living Donor Kidney Transplantation
Stanford University 22
Early research (Phase 1)Study completedNCT00376480
What this trial is testing

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Dana-Farber Cancer Institute 19
Testing effectiveness (Phase 2)Active Not RecruitingNCT02570542
What this trial is testing

Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma (DLBCL)Relapsed Diffuse Large B-cell Lymphoma (DLBCL)Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Memorial Sloan Kettering Cancer Center 59
Early research (Phase 1)Study completedNCT00005796
What this trial is testing

Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors

Who this might be right for
Bone Marrow SuppressionBrain and Central Nervous System TumorsDrug/Agent Toxicity by Tissue/Organ
Indiana University 10
Testing effectiveness (Phase 2)Study completedNCT02644759
What this trial is testing

Transplantation of Autologous Stem Cells for the Treatment of Type 1 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 1Autoimmune DiseasesEndocrine System Diseases+3 more
Stem Cells Arabia 100
Not applicableStudy completedNCT00658385
What this trial is testing

Assess the Feasibility and Safety of Granulocyte Colony Stimulating Factor (GCSF) Mobilization of CD34+ Hematopoietic Progenitor Cells in Patients With Betathalassemia Major

Who this might be right for
Beta Thalassemia MajorCongenital Anemias
Memorial Sloan Kettering Cancer Center 5
Next Page